Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Entourage Health Corp V.ENTG

Alternate Symbol(s):  ETRGF

Entourage Health Corp. is a Canada-based license holder producing and distributing cannabis products for both the medical and adult-use markets. The Company owns and operates a 26,000 square feet indoor facility in Aylmer, Ontario (the Aylmer Facility), specializing in product development and fulfillment for both adult-use and medical cannabis. The Company is focused on building a portfolio of... see more

TSXV:ENTG - Post Discussion

Entourage Health Corp > Hexo Perhaps a Good Comparison to ENTG
View:
Post by Wrywisdom on Oct 28, 2021 1:47pm

Hexo Perhaps a Good Comparison to ENTG

Hexo is losing $1.99 per share, has only twice the revenues yet 5x the loss in comparison to ENTG, but sits at about $2.00 per share.  Similar to the now estabished 5 year contractual relationship Entourage has with Boston Beer, Hexo is working with Molson Coors.

          As an aside, Hexo press releases strike me as not nearly as regular, well written, transparent or rich with detail.

          In the case of Entourage, they will soon be realizing massive additional revenues and profits from the sale of cannabis for cannabis beverage production, and for exclusive distribution throughout Canada of the final product. Little infrastructure investment is required for this major cooperative venture, as they add even further dimension to their now well established reliable tapestry of products.

          It is important also to remember that they have have a special license to sell directly to the general public sans the middleman including to the union members serviced by Starseed (and often paid for by Government Health in Canada); and also have distribution networks in 95% of Canada. No doubt distribution was an important factor for Boston Beer in establishing a 5 year contract with them.

          Some folks seem concerned about the CannTx acquisition. I am not even convinced it would be a good idea as ENTG already has such a diversified portfolio of reputed cannabis products and production contracts including with Fire an Flower, Mary's Medicinals, Pax, and Boston Beer.
Comment by Bunchofbros on Oct 28, 2021 11:20pm
Id be rich AF if it went to 1.99 lol 
Comment by Wrywisdom on Oct 29, 2021 2:58pm
Right. A 32k investment right now will yield $400,000. with ENTG at $2.00 per share. A very real possibility within 1 year with such a rich diversified portfolio of attractive highly regarded offerings on their plate, Starseed, Shopper's Drug Mart, Distribution Infrastructure and much more.
Comment by Nicksonsnowboar on Nov 01, 2021 10:45am
Yes they are alike both losing money, both striving for bankruptcy, both hitting new lows and yes they are the only two weed stocks down again today by a 6:1 ratio. Maybe they should amalgamate . They have a lot in common. Where is Moe 
Comment by Bunchofbros on Nov 01, 2021 12:56pm
Literally not down again today lol
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities